BMT CTN Protocol 0402

A Phase III Randomized, Multicenter Trial Comparing
Sirolimus/Tacrolimus with Tacrolimus/Methotrexate as GVHD Prophylaxis After HLA-Matched, Related Peripheral Blood Stem Cell Transplantation

Below are protocol-related documents, which may be periodically updated.

This study will close to new patient accrual on October 28, 2011; therefore, site participation application are no longer being accepted.